XML 22 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
OTHER CURRENT LIABILITIES (Details) (USD $)
Jun. 30, 2014
Dec. 31, 2013
Other Liabilities Disclosure [Abstract]    
Accrued payroll and commission costs $ 1,207,486 $ 941,313
Accrued clinical trial costs 725,723 129,208
Accrued vacation costs 406,597 256,920
Allowance for wholesale distributor fees 273,026 306,303
Accrued legal and accounting expense 192,972 224,550
Accrued royalties 155,221 52,188
Allowance for coupons and returns 107,007 126,233
Accrued rent 94,435  
Other accrued expenses 166,951 [1] 177,900 [1]
Accrued financing costs   850,000
Accrued lab research   536,574
TOTAL OTHER CURRENT LIABILITIES $ 3,329,418 $ 3,601,189
[1] In June 2008, we declared and paid a special dividend of $0.40 per share of our common stock to all stockholders of record as of June 10, 2008, of which $41,359 remained unclaimed by certain shareholders at March 31, 2014 and December 31, 2013.